Barclays Downgrades Myriad Genetics (MYGN) to Equalweight

August 10, 2016 7:40 AM

Barclays downgraded Myriad Genetics (NASDAQ: MYGN) from Overweight to Equalweight ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found